Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.10), MarketWatch Earnings reports. Bioceres Crop Solutions had a net margin of 3.56% and a return on equity of 5.37%. The business had revenue of $104.70 million during the quarter, compared to analyst estimates of $96.59 million. During the same quarter last year, the firm posted ($0.12) EPS.
Bioceres Crop Solutions Price Performance
Shares of Bioceres Crop Solutions stock traded up $0.13 on Wednesday, hitting $11.13. The company’s stock had a trading volume of 2,813 shares, compared to its average volume of 59,141. Bioceres Crop Solutions has a 52-week low of $9.76 and a 52-week high of $15.13. The company has a quick ratio of 0.89, a current ratio of 1.39 and a debt-to-equity ratio of 0.43. The firm has a fifty day moving average price of $12.14 and a 200-day moving average price of $11.82. The company has a market capitalization of $704.85 million, a P/E ratio of 55.00 and a beta of 0.42.
Institutional Investors Weigh In On Bioceres Crop Solutions
Several institutional investors and hedge funds have recently made changes to their positions in the business. Advisor Group Holdings Inc. lifted its holdings in Bioceres Crop Solutions by 66.9% in the 4th quarter. Advisor Group Holdings Inc. now owns 2,242 shares of the company’s stock valued at $27,000 after purchasing an additional 899 shares in the last quarter. Lazard Asset Management LLC purchased a new position in Bioceres Crop Solutions in the 4th quarter valued at about $49,000. Goldman Sachs Group Inc. purchased a new position in Bioceres Crop Solutions in the 2nd quarter valued at about $176,000. Sei Investments Co. purchased a new position in Bioceres Crop Solutions in the 2nd quarter valued at about $221,000. Finally, UBS Group AG purchased a new position in Bioceres Crop Solutions in the 2nd quarter valued at about $302,000. 13.35% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates in three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops.
- Five stocks we like better than Bioceres Crop Solutions
- Best Stocks Under $5.00
- 3 Reasons Dollar General Shares Belong in the Shopping Cart
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Shell’s 4.12% Dividend Yield: An Attractive Feature for Investors
- Stock Analyst Ratings and Canadian Analyst Ratings
- Apple Shares Stumble Into The Buy Zone
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.